These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Monti D; Vodopivec B; Basilico N; Olliaro P; Taramelli D Biochemistry; 1999 Jul; 38(28):8858-63. PubMed ID: 10413458 [TBL] [Abstract][Full Text] [Related]
3. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993 [TBL] [Abstract][Full Text] [Related]
4. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). Egan TJ; Ross DC; Adams PA FEBS Lett; 1994 Sep; 352(1):54-7. PubMed ID: 7925942 [TBL] [Abstract][Full Text] [Related]
5. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Dorn A; Vippagunta SR; Matile H; Jaquet C; Vennerstrom JL; Ridley RG Biochem Pharmacol; 1998 Mar; 55(6):727-36. PubMed ID: 9586944 [TBL] [Abstract][Full Text] [Related]
6. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. Basilico N; Pagani E; Monti D; Olliaro P; Taramelli D J Antimicrob Chemother; 1998 Jul; 42(1):55-60. PubMed ID: 9700528 [TBL] [Abstract][Full Text] [Related]
7. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378 [TBL] [Abstract][Full Text] [Related]
8. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity. Wicht KJ; Combrinck JM; Smith PJ; Egan TJ Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118 [TBL] [Abstract][Full Text] [Related]
9. A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Dorn A; Vippagunta SR; Matile H; Bubendorf A; Vennerstrom JL; Ridley RG Biochem Pharmacol; 1998 Mar; 55(6):737-47. PubMed ID: 9586945 [TBL] [Abstract][Full Text] [Related]
10. Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study. Bachhawat K; Thomas CJ; Surolia N; Surolia A Biochem Biophys Res Commun; 2000 Oct; 276(3):1075-9. PubMed ID: 11027592 [TBL] [Abstract][Full Text] [Related]
11. Binding of antimalarial drugs to hemozoin from Plasmodium berghei. Jearnpipatkul A; Govitrapong P; Yuthavong Y; Wilairat P; Panijpan B Experientia; 1980 Sep; 36(9):1063-4. PubMed ID: 6998717 [TBL] [Abstract][Full Text] [Related]
12. Formation of haemozoin/beta-haematin under physiological conditions is not spontaneous. Pandey AV; Tekwani BL FEBS Lett; 1996 Sep; 393(2-3):189-93. PubMed ID: 8814287 [TBL] [Abstract][Full Text] [Related]
13. A fine balance between oxidised and reduced haem controls the survival of intraerythrocytic plasmodia. Taramelli D; Monti D; Basilico N; Parapini S; Omodeo-Salé F; Olliaro P Parassitologia; 1999 Sep; 41(1-3):205-8. PubMed ID: 10697858 [TBL] [Abstract][Full Text] [Related]
14. Computational insights into the inhibition of β-haematin crystallization by antimalarial drugs. Delpe Acharige AMDS; Brennan MPC; Lauder K; McMahon F; Odebunmi AO; Durrant MC Dalton Trans; 2018 Nov; 47(43):15364-15381. PubMed ID: 30298161 [TBL] [Abstract][Full Text] [Related]
15. Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance. Warhurst DC; Craig JC; Raheem KS PLoS One; 2016; 11(8):e0160091. PubMed ID: 27483471 [TBL] [Abstract][Full Text] [Related]
17. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives. Vijayaraghavan S; Mahajan S Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947 [TBL] [Abstract][Full Text] [Related]
18. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin. Baelmans R; Deharo E; Muñoz V; Sauvain M; Ginsburg H Exp Parasitol; 2000 Dec; 96(4):243-8. PubMed ID: 11162377 [TBL] [Abstract][Full Text] [Related]
19. In vivo uptake of a haem analogue Zn protoporphyrin IX by the human malaria parasite P. falciparum-infected red blood cells. Sartorello R; Budu A; Bagnaresi P; Fernandes CA; Sato PM; Bueno VB; Fontes MR; Oliveira PL; Paiva-Silva GO; Alves SV; Netto LE; Catalani LH; Garcia CR Cell Biol Int; 2010 Aug; 34(8):859-65. PubMed ID: 20491653 [TBL] [Abstract][Full Text] [Related]
20. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]